Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rockwell Medical (RMTI) Interest Expenses (2019 - 2025)

Historic Interest Expenses for Rockwell Medical (RMTI) over the last 9 years, with Q3 2025 value amounting to $285000.0.

  • Rockwell Medical's Interest Expenses fell 562.91% to $285000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year decrease of 4563.43%. This contributed to the annual value of $1.3 million for FY2024, which is 4550.2% down from last year.
  • Latest data reveals that Rockwell Medical reported Interest Expenses of $285000.0 as of Q3 2025, which was down 562.91% from $276000.0 recorded in Q2 2025.
  • Rockwell Medical's Interest Expenses' 5-year high stood at $1.1 million during Q4 2023, with a 5-year trough of $232000.0 in Q2 2024.
  • For the 5-year period, Rockwell Medical's Interest Expenses averaged around $457578.9, with its median value being $431000.0 (2024).
  • In the last 5 years, Rockwell Medical's Interest Expenses surged by 46960.78% in 2021 and then tumbled by 7391.7% in 2024.
  • Quarter analysis of 5 years shows Rockwell Medical's Interest Expenses stood at $588000.0 in 2021, then dropped by 25.34% to $439000.0 in 2022, then soared by 152.39% to $1.1 million in 2023, then plummeted by 73.92% to $289000.0 in 2024, then fell by 1.38% to $285000.0 in 2025.
  • Its Interest Expenses was $285000.0 in Q3 2025, compared to $276000.0 in Q2 2025 and $277000.0 in Q1 2025.